Caeli Nova has successfully closed its Series A round of financing. This latest round of investment will allow the breathing technology developer to take greater strides in enhancing its technology, and to bring its first products to the market. Cordillera, Caeli Nova’s launch product, is an advanced aircraft emergency oxygen system that overcomes limitations associated with the existing technology, while significantly reducing costs and carbon emissions for airlines by enabling aircraft to fly the most direct routes. The company is aiming to install Cordillera onto first aircraft during 2022. LG Capital, Switzerland-based venture builder and co-founder of Caeli Nova, spearheaded
This content is restricted to site members.
If you are an existing user, please login below.
New users may register below.